Lei Yong Selected Research

oleandrin

7/2019	Oleandrin sensitizes human osteosarcoma cells to cisplatin by preventing degradation of the copper transporter 1.
12/2018	Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathway.
11/2016	Regulation of Intrinsic and Extrinsic Apoptotic Pathways in Osteosarcoma Cells Following Oleandrin Treatment.
10/2015	Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Yong Research Topics

Disease

6	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 10/2015
6	Neoplasms (Cancer) 01/2021 - 10/2015
4	Chordoma 01/2020 - 09/2017
1	Carcinogenesis 01/2019
1	Neoplasm Metastasis (Metastasis) 10/2015
1	Sarcoma (Soft Tissue Sarcoma) 10/2015

Drug/Important Bio-Agent (IBA)

4	oleandrinIBA 07/2019 - 10/2015
3	Cisplatin (Platino)FDA LinkGeneric 07/2019 - 09/2017
2	Zinc Oxide FDA Link 01/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Dynamins (Dynamin)IBA 01/2021
1	N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	LigandsIBA 01/2020
1	HhAntag691IBA 01/2020
1	Copper Transporter 1IBA 07/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	DAPIIBA 12/2018
1	Sincalide FDA Link 12/2018
1	p38 Mitogen-Activated Protein KinasesIBA 12/2018
1	Proteins (Proteins, Gene)FDA Link 09/2017
1	CateninsIBA 10/2015

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2020 - 10/2015
1	Radiotherapy 01/2020
1	Therapeutics 01/2019